These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1435288)

  • 1. Effects of intralipid-induced hypertriglyceridemia on plasma high-density lipoprotein metabolism in the cynomolgus monkey.
    Goldberg IJ; Vanni TM; Ramakrishnan R
    Metabolism; 1992 Nov; 41(11):1176-84. PubMed ID: 1435288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
    Leroux G; Lemieux I; Lamarche B; Cantin B; Dagenais GR; Lupien PJ; Després JP
    Metabolism; 2000 Jan; 49(1):53-61. PubMed ID: 10647064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.
    Hayek T; Azrolan N; Verdery RB; Walsh A; Chajek-Shaul T; Agellon LB; Tall AR; Breslow JL
    J Clin Invest; 1993 Sep; 92(3):1143-52. PubMed ID: 8376576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat.
    Huesca-Gómez C; Franco M; Luc G; Montaño LF; Massó F; Posadas-Romero C; Pérez-Méndez O
    Metabolism; 2002 Apr; 51(4):443-50. PubMed ID: 11912551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey.
    Goldberg IJ; Le NA; Paterniti JR; Ginsberg HN; Lindgren FT; Brown WV
    J Clin Invest; 1982 Dec; 70(6):1184-92. PubMed ID: 7174789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.
    Ginsberg HN; Ngai C; Wang XJ; Ramakrishnan R
    Arterioscler Thromb; 1993 Jun; 13(6):842-51. PubMed ID: 8499404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
    Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptozotocin-induced diabetic cynomolgus monkey is a model of hypertriglyceridemia with low high-density lipoprotein cholesterol.
    Tsutsumi K; Iwamoto T; Hagi A; Kohri H
    Biol Pharm Bull; 1998 Jul; 21(7):693-7. PubMed ID: 9703251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.
    Goldberg IJ; Le NA; Ginsberg HN; Krauss RM; Lindgren FT
    J Clin Invest; 1988 Feb; 81(2):561-8. PubMed ID: 3276735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.